These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34621768)

  • 1. The Active Compounds and Therapeutic Target of
    Liu P; Zhang J; Wang Y; Shen Z; Wang C; Chen DQ; Qiu X
    Front Med (Lausanne); 2021; 8():747922. PubMed ID: 34621768
    [No Abstract]   [Full Text] [Related]  

  • 2. Functions and targets of miRNAs in pharmacological and toxicological effects of major components of Tripterygium wilfordii Hook F.
    Pan W; Yang B; He D; Chen L; Fu C
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):1997-2019. PubMed ID: 37831113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis.
    Ru Y; Li H; Zhang R; Luo Y; Song J; Kuai L; Xing M; Hong S; Sun X; Ding X; Lu Y; Liu L; Na C; Zhou Y; Li B; Li X
    Phytomedicine; 2020 Oct; 77():153299. PubMed ID: 32823074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mechanistic Overview of Triptolide and Celastrol, Natural Products from
    Chen SR; Dai Y; Zhao J; Lin L; Wang Y; Wang Y
    Front Pharmacol; 2018; 9():104. PubMed ID: 29491837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
    Jin D; Yu M; Li X; Wang X
    J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications and Mechanisms of Tripterygium
    Tong X; Qiao Y; Yang Y; Liu H; Cao Z; Yang B; Wei L; Yang H
    Front Pharmacol; 2022; 13():846746. PubMed ID: 35387327
    [No Abstract]   [Full Text] [Related]  

  • 7. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for the therapeutic effect of
    Zhao J; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):573-582. PubMed ID: 35753727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders.
    Liu X; Lin L; Lv T; Lu L; Li X; Han Y; Qiu Z; Li X; Li Y; Song X; Cao W; Li T
    Phytomedicine; 2022 Jul; 101():154103. PubMed ID: 35468451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide: progress on research in pharmacodynamics and toxicology.
    Li XJ; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of
    Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
    Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lengnan X; Ban Z; Haitao W; Lili L; Aiqun C; Huan W; Ping Z; Yonghui M
    Biomed Res Int; 2020; 2020():9181037. PubMed ID: 32596393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of triptolide and the molecular mechanisms involved.
    Xi C; Peng S; Wu Z; Zhou Q; Zhou J
    Biomed Pharmacother; 2017 Jun; 90():531-541. PubMed ID: 28402922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
    Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
    Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.
    Zhang Y; Mao X; Li W; Chen W; Wang X; Ma Z; Lin N
    Med Res Rev; 2021 May; 41(3):1337-1374. PubMed ID: 33296090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns.
    Li M; Luo Q; Chen X; Qiu F; Tao Y; Sun X; Liu C
    BMC Complement Med Ther; 2023 Jan; 23(1):9. PubMed ID: 36627617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Based on Network Pharmacology Tools to Investigate the Mechanism of
    Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
    Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
    [No Abstract]   [Full Text] [Related]  

  • 19. Tripterygium wilfordii Hook.f induced kidney injury through mediating inflammation via PI3K-Akt/HIF-1/TNF signaling pathway: A study of network toxicology and molecular docking.
    Yang S; Wang M; Li Z; Luan X; Yu Y; Jiang J; Li Y; Xie Y; Wang L
    Medicine (Baltimore); 2024 Feb; 103(6):e36968. PubMed ID: 38335377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR.
    Xiong C; Li L; Bo W; Chen H; XiaoWei L; Hongbao L; Peng Z
    J Formos Med Assoc; 2020 Mar; 119(3):685-692. PubMed ID: 31801679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.